Saving Human Lives

One At a Time

Developing innovative life-saving therapies to patients

Welcome To Enzychem

Our Values
Our Values
About Enzychem
About Enzychem
Research & Development
Research & Development
Responsibility
Responsibility
History
History
Partnership
Partnership
Clinical Pipeline

Clinical Pipeline

One deep-rooted belief we hold here at Enzychem Lifesciences is that any form of treatment should be accessible to patients all over the world. As we pursue to develop a global new drug, our team carries the important duty of ensuring EC-18’s efficacy backed up by comprehensive studies. Enzychem has commenced clinical trials in 2016, and since then, we have been conducting ongoing research in the drug’s effects on patients with one of various conditions.

Read More
Clinical Program

Clinical Program

The global drug development program at Enzychem entails an extensive sequence of clinical studies on the safety and efficacy of EC-18 in various indications.

Read More

Latest News

March 27, 2019 Enzychem Lifesciences Announces Poster Presentations at the AACR 2019 Annual Meeting Read More
February 21, 2019 Enzychem Lifesciences Completes Stage 1 Patient Enrollment in Phase 2 CRIOM Study Read More
December 31, 2018 Enzychem Lifesciences To Present At Biotech Showcase™ 2019 In San Francisco Read More
July 19, 2018 Enzychem Lifesciences held Launch Ceremony in USA Read More

Enzychem Lifesciences Corporation

is a Global New Drug Development Company that was founded on the most advanced life sciences and technologies of medicinal chemistry in July 1999. With its Global New Drug R&D center located in KAIST in Daejeon and its two GMP manufacturing plants in Seoul, it has since been developing and producing APIs and functional health foods, and developing global new drugs as the leader of the field.

Read More